Daniel E. Abbott, MD, FACS
Professor
- Surgical Director, UW Health Liver and Pancreas Center
- Division of Surgical Oncology
abbott@surgery.wisc.edu
(608) 262-2025
- Administrative Assistant: (608) 262-2025
600 Highland Avenue
Box 7375, Clinical Science Center
Madison, WI 53792
Education
- MD, University of Washington School of Medicine, Seattle, Washington
- General Surgery Residency, Northwestern University/Feinberg School of Medicine, Chicago, Illinois
- Research Fellowship, Children's Memorial Research Center/Northwestern University, Division of Cancer Biology and Epigenomics, Chicago, Illinois
- Surgical Oncology Fellowship, Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas
Clinical Specialties
Dr. Abbott is certified by the American Board of Surgery and is a Fellow of the American College of Surgeons. Trained specifically in cancer surgery at The University of Texas MD Anderson Cancer Center, his clinical focus is on gastrointestinal malignancies, as well as melanoma and sarcoma. He performs both traditional and laparoscopic resections for cancers of the liver, pancreas, and stomach. As Director of Cytoreductive and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Surgery, he is particularly interested in patients with peritoneal spread of appendiceal, colorectal and ovarian cancers. Dr. Abbott is active in a number of national organizations, including the Society of Surgical Oncology, the American Hepatopancreaticobiliary Association, the Association for Academic Surgery, and the Society of University Surgeons.
Dr. Abbott provides a wide range of services including Bile Duct Resection, Caudate Resection, Cryoablation, Cyst Fenestration (Unroof Liver Cyst), Cytoreductive Surgery with HIPEC, Frey Procedure, Gastrectomy – Partial or Total, Hemihepatectomy (Hepatectomy), Laparoscopic Liver Resection, Laparoscopic Pancreatectomy, Liver Resection, Liver Tumor Ablations, Melanoma Completion Lymph Node Dissection (Axillary and Groin), Melanoma Sentinel Lymph Node Biopsy, Melanoma Wide Local Excision and Skin Closure, Obstructed Pancreatic Duct Drainage (Peustow Procedure), Pancreatic Head Resection, Pancreaticoduodenectomy, Pancreatic Pseudocysts Drainage, Pancreatic Resections, Radical Cholecystectomy, Radiofrequency Ablation, Right / Left Extended Hemihepatectomy (Hepatectomy), Wedge Resection of the Liver, Whipple Procedure.
Research Interests
Dr. Abbott, a health services researcher, focuses on cost-effectiveness, systems efficiency, and socioeconomic disparity in cancer care. He is particularly interested in identifying opportunities to maintain or enhance cancer care using technology in a patient-centered manner and thereby helping patients access expert cancer care in more personalized settings.
Recent Publications
Subclonal response heterogeneity to define cancer organoid therapeutic sensitivity.
Kratz JD, Rehman S, Johnson KA, Gillette AA, Sunil A, Favreau PF, Pasch CA, Miller D, Zarling LC, Yeung AH, Clipson L, Anderson SJ, Steimle AK, Sprackling CM, Lemmon KK, Abbott DE, Burkard ME, Bassetti MF, Eickhoff JC, Foley EF, Heise CP, Kimple RJ, Lawson EH, LoConte NK, Lubner SJ, Mulkerin DL, Matkowskyj KA, Sanger CB, Uboha NV, Mcilwain SJ, Ong IM, Carchman EH, Skala MC, Deming DA
Sci Rep 2025 Apr 09; 15(1): 12072
[PubMed ID: 40200028]Postoperative hepatic insufficiency despite preoperative portal vein embolization: Not just about the volumetrics.
Li AY, Ahmad MU, Sofilos MC, Lee RM, Maithel SK, Lee TC, Chadalavada S, Shah SA, Acher AW, Abbott DE, Wong P, Kessler J, Melstrom LG, Kirks R, Rocha FG, Delitto DJ, Lee B, Visser BC, Poultsides GA
Surgery 2025 Mar 28; 182: 109345
[PubMed ID: 40157125]Neoadjuvant SBRT plus Elective Nodal Irradiation with Concurrent Capecitabine for Patients with Resectable Pancreatic Cancer: Survival Analysis of a Prospective Phase 1 Trial.
Basree MM, Witt JS, Uboha NV, Lubner M, Minter R, Weber S, Ronnekleiv-Kelly S, Abbott D, Kratz J, Patel M, Zafar SN, LoConte N, Lubner SJ, Deming D, Ritter MA, Mohindra P, Bassetti MF
Pract Radiat Oncol 2025 Feb 07;
[PubMed ID: 39924052]Long term outcomes associated with the use of perioperative systemic chemotherapy on low grade appendiceal mucinous neoplasms with pseudomyxoma peritonei treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
Ruff SM, Kasumova G, Palavalli M, Eng OS, Lambert L, Clarke C, Patel S, Veerapong J, Fournier K, Abbott D, Staley C, Grotz T, Johnston F, Raoof M, Dineen S, Cloyd JM, Kim AC
Front Oncol 2024; 14: 1456920
[PubMed ID: 39850813]Lymph node metrics following neoadjuvant therapy to refine patient selection for adjuvant chemotherapy in resected pancreatic cancer: A multi-institutional analysis.
Amirian H, Dickey E, Ogobuiro I, Box EW, Shah A, Martos MP, Patel M, Wilson GC, Snyder RA, Parikh AA, Hammill C, Kim HJ, Abbott D, Maithel SK, Zafar SN, LeCompte MT, Kooby DA, Ahmad SA, Merchant NB, Hester CA, Datta J
J Surg Oncol 2024 Oct; 130(5): 1023-1032
[PubMed ID: 39165230]